CSL Limited
CSLLYOTCHealthcare● Active
$17.12
+$0.00(+0.00%)
Market Cap$66.3B
P/E Ratio—
52W High$44.855
52W Low$16.29
CSL Limited（CSLLY）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · CSLLY · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-06 | 2024-06 | 2023-06 | 2022-06 | 2021-06 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.00B | $2.69B | $2.22B | $2.15B | $2.38B |
| Depreciation & Amort. | $0.00B | $0.95B | $0.82B | $0.52B | $0.50B |
| Stock-Based Comp. | $0.00B | $0.00B | $0.14B | $0.12B | $0.09B |
| Change in Working Capital | ($0.88B) | ($1.59B) | ($0.62B) | ($0.80B) | ($0.27B) |
| Net Cash from Operations | $3.56B | $2.76B | $2.60B | $2.63B | $3.62B |
| Investing Activities | |||||
| Capital Expenditure | ($1.02B) | ($1.26B) | ($1.69B) | ($1.25B) | ($1.20B) |
| Purchases of Investments | $0.00B | $0.00B | $0.46B | ($0.39B) | $0.00B |
| Sales of Investments | $0.00B | $0.00B | $0.27B | $0.00B | $0.00B |
| Net Cash from Investing | ($0.85B) | ($1.26B) | ($11.84B) | ($1.64B) | ($1.67B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | ($1.43B) | ($1.21B) | ($1.07B) | ($0.99B) | ($0.96B) |
| Debt Issued / Repaid | ($0.73B) | $0.04B | $1.74B | $3.78B | ($0.50B) |
| Net Cash from Financing | ($2.24B) | ($1.28B) | $0.46B | $7.68B | ($1.40B) |
| Free Cash Flow | |||||
| Free Cash Flow | $2.54B | $1.51B | $0.91B | $1.38B | $2.43B |
| FCF Margin %(computed) | 16.49% | 10.18% | 6.90% | 13.16% | 23.63% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解CSL Limited
关于CSL Limited（CSLLY）现金流量表
CSL Limited 2025财年经营活动现金流$3.56B，自由现金流$2.54B（FCF利润率16.49%），资本支出($1.02B)。
常见问题
CSLLY · 4 问CSL Limited 2025财年自由现金流$2.54B，同比up68.9%。
CSLLY free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10